AACC in the News

Here is a sampling of recent media coverage of AACC, its journal Clinical Chemistry, and its patient health site, www.labtestsonline.org.

Lab Professionals Oppose Draft Dx Reform Bill; Lab, IVD Industry Ready To Work With Congress
APR.13.2017 // Medtech Insight
The clinical lab industry and IVD test-kit-makers appear ready to work with lawmakers on diagnostic reforms that would create a new category of regulated product for all lab tests that would undergo a mix of US FDA and CMS oversight.

AACC Joins NEJM, Area9 to Launch Online Learning Platform
APR.2017 // Clinical OMICS
The American Association for Clinical Chemistry (AACC) has launched an online learning platform focused on laboratory medicine, through a collaboration with NEJM Group, publisher of the New England Journal of Medicine, and Area9 Learning.

Codexis Looks to Use Protein Engineering Prowess to Improve Molecular Diagnostic Performance
MAR.30.2017 // GenomeWeb
Claeboe noted that the company first began putting its feelers out at the American Association for Clinical Chemistry meeting last summer, "and we were simply asking the question: Would engineered enzymes in your workflow be beneficial?"

Cell-free DNA screening blooms in expansion to low-risk pregnancies
MAR.2017 // CAP Today
Dr. Palomaki, assistant director of the Division of Medical Screening and Special Testing at Women and Infants Hospital, was a speaker in a recent AACC webinar on cell-free DNA-based prenatal screening in the general pregnancy population.

Philadelphia Convention & Visitors Bureau Announces Highest Convention Booking Year Ever
MAR.3.2017 // Exhibit City News
“We are delivering on the promise of customer service and performing at a very high level for great customers such as World Meeting of Families, the Democratic National Convention, the American Association for Clinical Chemistry, and most recently, for a record-setting Philadelphia Auto Show,” PCC President & CEO John J. McNichol said.

Diagnostic laboratory reduced to the size of a microwave
FEB.27.2017 // Crisis Response
The Theranos miniLab was met not without skepticism from audience members at the 68th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo.

Star Trek Tricorders Left The Science Fiction Realm to Become Science Reality
FEB.24.2017 // Omni
Research teams have been working on the creation of a mobile diagnostic device inspired by the fictional medical Tricorder from Star Trek.

Qualcomm Tricorder Xprize competition reaches final round
FEB.24.2017 // Evaluation Engineering
Yesterday, the American Association for Clinical Chemistry (AACC) announced that Chung-Kang Peng, PhD, who leads the Taiwan-based Dynamical Biomarkers Group team, will present data on his team’s tricorder prototype in a special session at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego this summer.

In the Lab: As PAMA Reporting Deadline Looms, Labs Brace for Medicare Rate Cuts
FEB.10.2017 // Clinical OMICS
“If the rate that is reimbursed goes down for some of our tests to the point where our costs are not even covered, that might influence the ability of doctors to order those tests,” said David D. Koch, Ph.D., director of clinical chemistry, toxicology, and point-of-care testing at Grady Memorial Hospital in Atlanta, and Professor of Pathology & Laboratory Medicine at Emory University, and chair of the American Association for Clinical Chemistry’s Policy and External Affairs Core Committee.

Research raises questions on consistency of dialysis blood testing methods
FEB.03.2017 // CBS 19
New research has looked into the accuracy of a blood test used to determine the health and well-being of dialysis patients, but the results are raising concerns.

Consumers Increasingly Purchase Medical Laboratory Self-Test Kits for Blood Glucose, Cholesterol, and Colon Cancer Screening
JAN.20.2017 // Dark Daily
In addition to seeking control over their healthcare, patients are also motivated by convenience and privacy, noted a Lab Tests Online article.

Silicon Valley Should Drop Its Obsession With Apple-esque Secrecy
JAN.18.2017 // The Motley Fool
Too bad Holmes instead chose to use her presentation at that month's American Association for Clinical Chemistry's annual meeting in Philadelphia primarily to pitch a new product.

13 Notable U.S. Health Care Trade Shows
JAN.17.2017 // Trade Show News Network
American Association for Clinical Chemistry Annual Meeting & Clinical Lab Expo – July 30-Aug. 3, 2017. This is a show that appreciates marketing innovation from its more than 750 exhibitors and has an international buyers’ program.

Silicon Valley Cash Is Still Chasing Blood Despite Theranos Bust
JAN.6.2017 // Bloomberg Technology
“I’m impressed,” said Patricia Jones, 2016 president of the American Association for Clinical Chemistry, after reviewing the data. “The game-changing part of this would be being able to do testing and potentially make a diagnosis immediately, instead of having to send out lab tests, wait several days, then call the patient.”

Theranos cuts 41% of workforce as it concentrates on miniLab
JAN.6.2017 // MedCity News
CEO Elizabeth Holmes previewed miniLab in August at a much-panned appearance at the American Association for Clinical Chemistry Annual Scientific Meeting in Philadelphia.

Theranos is laying off 41% of its staff
JAN.6.2017 // Yahoo Finance
Theranos is going through its second round of layoffs.

Theranos is laying off 41% of its staff
JAN.6.2017 // Banking Industry Today
The blood-testing company confirmed it is laying off 41% of its staff, Bloomberg first reported.

Simple blood test can detect genetic diseases early in pregnancy
JAN.4.2017 // New Scientist
Together, single-gene disorders are more common than Down’s syndrome. Now there’s a safe prenatal test that can help prospective parents decide what to do.

Life Science Controversies of 2016
DEC.23.2016 // The Scientist
In August, Holmes gave a presentation at the American Association for Clinical Chemistry, in which—rather than addressing her firm’s existing technologies and issues—she presented the idea behind a new device, dubbed “miniLab.”

How Biotin Could Mess With Your Blood Work
DEC.14.2016 // Allure
A study in Clinical Laboratory News found that taking high doses of the vitamin might skew diagnostic test results, leading to false positives or false negatives for pregnancy, fertility, and even cancer screenings and monitoring.

President Obama has signed into law legislation to fund cancer research and battling drug abuse
DEC.13.2016 // WAGM TV
The Next Generation Researchers Act will establish the Next Generation of Researchers Initiative within the National Institutes of Health (NIH) Office of the Director to coordinate all current and new NIH policies to promote opportunities for our new scientists and earlier research independence.

Taking This Popular Supplement Can Screw Up Cancer Screening Results
DEC.9.2016 // Glamour
According to a new American Association for Clinical Chemistry report, biotin can lead to misreadings of hormone levels.

The past, present and future of FDA regulation of LDTs
DEC.9.2016 // Med City News
It has been more than two years since FDA notified Congress of its intention to issue draft guidance on a proposed regulatory framework for the oversight by FDA of laboratory developed tests.

More Americans Are Smoking Marijuana And Driving, But Identifying Them Is Tricky
DEC.2.2016 // Forbes
Huestis coauthored a study published in the February issue of Clinical Chemistry that found THC blood levels dropped from well above the legal threshold set by some states to below it within only about 3 1/2 hours of inhaling vaporized THC.

The Rise and Fall of a Disruptive Company: Theranos and its 32-year-old founder Elizabeth Holmes face probes and lawsuits
OCT.14.2016 // Epoch Times
“She went into the field of laboratory medicine without any kind of understanding of the strict regulatory environment,” said Dr. Patricia Jones, the president of American Association for Clinical Chemistry (AACC).

Downfall of a unicorn: How Theranos fell apart
OCT.10.2016 // BioPharmaDIVE
Last week, Theranos CEO and founder Elizabeth Holmes penned an open letter announcing the blood-testing startup would close its clinical labs and collection sites, laying off hundreds of employees in the process.

Bad Blood: The Decline And Fall Of Elizabeth Holmes And Theranos
OCT.8.2016 // Forbes
On October 5, Theranos got out of the business of drawing blood entirely. What happened?

Theranos seeks turnaround with a portable blood-testing device, but skepticism abounds
OCT.6.2016 // The Los Angeles Times
“There is a lot of skepticism,” said Patricia Jones, president of the American Assn. of Clinical Chemistry. “The verdict is still out.”

Theranos to Close Labs and Lay Off 340 Workers
OCT.5.2016 // The New York Times
In making the announcement, Ms. Holmes, who founded Theranos as Silicon Valley’s answer to conventional blood testing, completed the pivot she first proposed this past August.

Theranos will close labs and fire 340 employees
OCT.5.2016 // The Verge
The company will also develop the blood-testing device it showed off at the American Association for Clinical Chemistry, called the "miniLab," which is the size of a computer printer.

Theranos is closing its labs and Wellness Centers
OCT.5.2016 // Engadget
Despite all those issues, the company introduced the miniLab, which is different from its older proprietary machine called Edison, at the American Association for Clinical Chemistry in August.

Senate holds hearing to determine FDA oversight of laboratory developed tests
SEP.26.2016 // Life Science Daily
A senate hearing on laboratory testing was held on Tuesday to determine if regulation of laboratory developed tests (LDTs) should remain under the Clinical Laboratory Improvement Amendments (CLIA), or if Food & Drug Administration (FDA) oversight should be expanded.

Exclusive: How Elizabeth Holmes’s House of Cards Came Tumbling Down
SEP.06.2016 // Vanity Fair
In August, she flew to Philadelphia to speak at the American Association for Clinical Chemistry’s annual conference. The audience was hoping that Holmes would answer questions about her Edison technology and explain whether or not she knew it was a sham.

Theranos Halts New Zika Test After FDA Inspection
AUG.30.2016 // The Wall Street Journal
Theranos’s news release on Aug. 1 as Ms. Holmes spoke at the American Association for Clinical Chemistry’s annual meeting said the company believed no other test for Zika that uses tiny blood samples collected by finger sticks was available.

Cuyahoga Falls biz brings the medical testing to you
AUG.28.2016 // Crain's Cleveland Business
Haymond, a member of the Washington, D.C.-based American Association for Clinical Chemistry, said at-home testing can offer patients access to information and cost transparency, which can be empowering and are “certainly positive,” but a lot of unknowns remain about who’s using the tests, what their motivations are and how they’re using the results.

Theranos fights back
AUG.26.2016 // Business Insider
Earlier this month, Theranos debuted a new blood-testing system at the American Association for Clinical Chemistry's annual conference — its first medical conference appearance — that included a machine that takes the sample of blood and processes it so it can give a diagnosis or tell you your cholesterol level.

Theranos to Appeal Severe Government Sanctions
AUG.26.2016 // KQED
Earlier this month, Holmes attempted a fresh start by giving a much-anticipated presentation at the annual meeting of the American Association for Clinical Chemistry.

DNC Gives Philly Hotels 'Blockbuster' Summer, CVB Reports
AUG.18.2016 // Successful Meetings
Among the other events hosted in Philadelphia this summer were the Drug Information Association ($21.7 million in economic impact), the AME Church Bicentennial ($21.2 million), the American Podiatric Medical Association ($7.8 million in economic impact), the AVID Summer Institute ($8.2 million), and the American Association for Clinical Chemistry ($39.8 million).

Precision Medicine: Little Benefit So Far, But Lots of Hope
AUG.16.2016 // KQED
“In the majority of the clinical trials, the benefit has been very small, measured as two months of longer survival,” Antonio Fojo, an oncologist at Columbia University reported at the American Association for Clinical Chemistry in July.

Lesson of Theranos: Fact-Checking Alone Isn't Enough
AUG.8.2016 // Bloomberg View
You don’t have to be a scientist to see what was wrong with the outsized claims of Elizabeth Holmes, self-proclaimed medical disruptor.

Theranos Founder Elizabeth Holmes Had the Chance for Redemption – and She Blew It
AUG.5.2016 // Fortune
In a highly anticipated event, Theranos founder Elizabeth Holmes faced a crowd of more than a thousand of the world’s foremost experts on laboratory testing and medicine.

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More
AUG.5.2016 // Xconomy
Theranos CEO Elizabeth Holmes spoke at a conference for laboratory scientists this week in Philadelphia.

The Medical Community Isn’t Letting Theranos Off the Hook
AUG.4.2016 // Vanity Fair
An expert in the field of laboratory medicine weighs in on what went wrong at Theranos—and if Elizabeth Holmes has any hope of redemption.

Theranos Presents New Device to Lab Scientists at AACC
AUG.4.2016 // Laboratory Equipment
This week, embattled Theranos CEO Elizabeth Holmes took her technology somewhere it had never gone before: a scientific laboratory conference.

Vilified start-up Theranos seeks second chance at Philly conference
AUG.3.2016 // Philadelphia Inquirer
Elizabeth Holmes, founder and CEO of the once-celebrated biotech start-up Theranos Inc., came to Philadelphia on Monday with a mission.

‘Wakeup Call’ for Neurontin Abuse
AUG.3.2016 // Pain News Network
A drug that is often prescribed as an alternative to opioid pain medication is increasingly being abused by patients, according to a small study that found one out of five patients taking the drug illicitly.

Theranos CEO hopes "miniLab" may save company
AUG.2.2016 // CBS News
Elizabeth Holmes, who effectively became the youngest self-made female billionaire, is trying to rebuild her bio-tech brand after a series of missteps.

How Theranos’s reboot could backfire
AUG.2.2016 // The Washington Post
Theranos chief executive Elizabeth Holmes tried to kick off the beleaguered company's comeback story on Monday in front of a few thousand scientists and doctors.

Theranos Makes Case to Laboratory Experts
AUG.2.2016 // The Wall Street Journal
Theranos founder Elizabeth Holmes announced a new blood-testing device called "miniLab" Monday at a professional conference of the American Association for Clinical Chemistry.

Theranos Had a Chance to Clear Its Name. Instead, It Tried to Pivot
AUG.2.2016 // Wired
Many of the people gathered in that conference room at the 2016 annual meeting of the American Association of Clinical Chemistry were probably expecting the company to address those allegations, with data.

Elizabeth Holmes Is Being Accused of Pulling a ‘Bait and Switch’
AUG.2.2016 // Fortune
Theranos CEO Elizabeth Holmes pulled what some are calling a bait and switch, introducing new technology called the miniLab instead of addressing her company's highly publicized medical accuracy concerns.

The Founder of Theranos Tries to Change the Subject
AUG.2.2016 // The New Yorker
On Monday, Patricia Jones, the president of the American Association for Clinical Chemistry, made an unusual introduction at the sixty-eighth Annual Scientific Meeting and Clinical Lab Expo, in Philadelphia.

Theranos presented new products to scientists who were expecting data — and it didn't go over well
AUG.2.2016 // Business Insider
At Theranos' first presentation at a scientific conference, the information that was shared felt more like a product reveal than a discussion of the data that would help validate the company's blood-testing system.

Theranos chief pitches new blood-testing device amid caution
AUG.2.2016 // Chicago Tribune
Holmes pitched her presentation as an "inflection point," as she works to forge relations with the scientific and medical community.

Theranos CEO Faces Critics, Presents New Product Plans
AUG.2.2016 // Scientific American
It was her first public appearance since the privately held company and Holmes personally were sanctioned by the U.S. government's Centers for Medicare & Medicaid Services.

Theranos ignores scandal and shows off new blood-testing machine
AUG.2.2016 // The Verge
Only one Theranos blood testing product has been approved by the FDA so far — a herpes test — while the company's others were covered by a regulatory loophole that allowed them to be sold as lab-developed tests.

Theranos CEO unveils 'miniLab' at Philadelphia conference
AUG.2.2016 // Philadelphia Business Journal
The product, which is about the size of a bread machine, has not yet been submitted to the Food and Drug Administration for approval.

With chance to soothe Theranos’ critics with data, Holmes gives sales pitch
AUG.2.2016 // Ars Technica
Holmes spent her entire 45-minute time slot talking about a new blood testing device called the miniLab. Any questions about the company's old, disastrous blood testing device (the Edison) were flatly refused—even including questions about the differences between the Edison and miniLab.

One question got at the heart of all the confusion around the technology Theranos uses
AUG.2.2016 // Business Insider
Theranos presented its technology to an audience on Monday packed with scientists who know the blood-testing world inside and out. And it didn't go quite as people expected.

Theranos chief pitches new blood-testing device amid caution
AUG.2.2016 // Chicago Tribune
Holmes, who spoke at a meeting of the American Association for Clinical Chemistry, avoided the long list of regulatory and credibility problems that face the company she founded in 2003, when she was 19.

Skeptical reaction at Theranos' coming out party
AUG.2.2016 // CNN
The American Association of Clinical Chemistry has one of the more popular professional conventions in the science world, but when security had to scold a scientist for running to get one of the limited number of seats for a presentation, it may have been an association first.

Theranos intros new 'fingerprick' testing tech despite its woes
AUG.2.2016 // Engadget
Theranos founder Elizabeth Holmes has introduced a 95-pound testing device called "miniLab" at the American Association for Clinical Chemistry meeting in Philadelphia.

Theranos CEO Elizabeth Holmes trades new, unproven tech for old
AUG.2.2016 // San Francisco Chronicle
At this point, you’ve got to wonder whether Theranos CEO Elizabeth Holmes is just making it up as she goes along, or if her actions constitute some kind of mad, genius plan.

What Elizabeth Holmes did and didn't disclose about Theranos at AACC
AUG.2.2016 // Becker's Hospital Review
Elizabeth Holmes, founder and CEO of Theranos, took the stage Monday evening at the American Association for Clinical Chemistry in Philadelphia to present new technologies and prove there is more to the Palo Alto, Calif.-based startup than a series of clinical laboratory issues.

ANGLE’s Parsortix to be in focus at AACC annual meeting
AUG.2.2016 // Proactive Investors
ANGLE PLC’s (OTCMKTS:ANPCY, LON:AGL) Parsortix device will be the focus of a poster presentation at the American Association for Clinical Chemistry (AACC) annual meeting later today.

Innovative Test That Could Predict Risk of Kidney Failure in Pediatric Type 1 Diabetes Patients Announced at 68th AACC Annual Scientific Meeting
AUG.2.2016 // Yahoo News
Researchers have successfully tested a new method for the early diagnosis in children and teenagers of diabetic nephropathy, a serious complication of diabetes that can increase risk of death.

Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016
AUG.2.2016 // Yahoo News
Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, will exhibit its expanded offering of new assays, instruments and software at the 2016 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo being held July 31 - August 4 at the Pennsylvania Convention Center.

New diagnostic tool could make detecting Zika cheap and easy
AUG.1.2016 // The Verge
A new diagnostic tool could make detecting Zika infection in patients much easier and cheaper in remote areas of Latin and Central America.

Theranos, Embattled Laboratory, Shifts to Medical Machines
AUG.1.2016 // The New York Times
Elizabeth Holmes tried to salvage the reputation of her embattled blood-testing company here on Monday, discussing its technology and data at a scientific meeting for the first time.

Under siege, Theranos introduces a new technology
AUG.1.2016 // Washington Post
With her controversial blood-testing company under intense federal scrutiny, Theranos chief executive Elizabeth Holmes took the stage before hundreds of medical laboratory experts on Monday to present a new blood-testing device and bat down questions about a series of blunders that have thrust the company into crisis.

Theranos Makes Case to Laboratory Experts
AUG.1.2016 // The Wall Street Journal
Theranos Inc. founder Elizabeth Holmes announced a new blood-testing device at an academic conference here Monday but didn’t address problems found with the company’s earlier machines.

Expecting Data From Theranos, Lab Experts Get New Product
AUG.1.2016 // Bloomberg
It was expected to be an academic presentation to show if Theranos Inc.’s controversial blood-testing technology worked, and perhaps explain the science behind the claims that the startup could do lab tests with a fraction of the blood and cost of traditional machines.

Theranos just presented in front of thousands of scientists, but some big questions remain
AUG.1.2016 // Business Insider
Theranos, the Silicon Valley blood-testing company that's been under fire for almost a year, presented at a scientific conference for the first time on Monday.

Here's how Theranos CEO plans to lift the lid on its testing methods
AUG.1.2016 // CNBC
Theranos CEO Elizabeth Holmes outlined the steps she will take to increase transparency regarding the efficacy of the company's testing methods.

Live Blog: Theranos' Elizabeth Holmes Presents New Blood-Testing Machine
AUG.1.2016 // Forbes
Elizabeth Holmes is personally presenting data about a new machine developed by her embattled blood testing startup, Theranos, here at the annual meeting of the American Association for Clinical Chemistry. For my early thoughts on the presentation, read this. I’ll be live-blogging the presentation until my laptop battery dies.

Theranos' Highly-Anticipated Defense of Its Tech Is Called a 'Bait-and-Switch'
AUG.1.2016 // Fortune
Elizabeth Holmes, CEO of embattled blood testing company Theranos, was expected by many to share information about her controversial diagnostics technology during a highly anticipated appearance at a medical conference on Monday.

Elizabeth Holmes’s First Public Presentation of Theranos Data Falls Short
AUG.1.2016 // Vanity Fair
Attendees of Elizabeth Holmes’s highly anticipated (and somewhat controversial) presentation at a healthcare convention in Philadelphia probably expected the embattled Theranos C.E.O. to focus on defending her company’s signature blood-testing technology, which has come under intense scrutiny from regulators.

Scientists Wanted Transparency From Theranos, But Got A Product Launch Instead
AUG.1.2016 // Fast Company
Theranos once promised to revolutionize the blood testing industry. But its methodology remains secretive, despite calls for transparency from the scientific community.

Theranos Unveils “MiniLab” Invention to a Skeptical Audience
AUG.1.2016 // MIT Technology Review
Elizabeth Holmes, CEO of embattled blood-testing company Theranos, on Monday boldly took her company’s technology where it had never gone before: a medical conference.

Theranos CEO faces critics, presents new product plans
AUG.1.2016 // Yahoo News
Members of the audience applauded several times when doctors on the stage challenged aspects of Theranos technology.

Theranos CEO faces critics, presents new product plans
AUG.1.2016 // Reuters
Prior to introducing Holmes, association president Patricia Jones said the organization does not endorse Theranos. "We're all aware that there have been some suggestions about whether we'll see some science today and the viability of Theranos technology," Jones said.

Theranos CEO speaks at AACC
AUG.1.2016 // CNBC
Theranos CEO Elizabeth Holmes tries to convince experts her company's controversial blood testing technology actually works at the AACC. 

Embattled leader of Theranos pitches new blood-testing device
AUG.1.2016 // Houston Chronicle
It was expected to be an academic presentation to show if Theranos's controversial blood-testing technology worked, and perhaps explain the science behind the claims that the startup could do lab tests with a fraction of the blood and cost of traditional machines.

BRIEF-Theranos unveils diagnostic-testing technologies at AACC meeting
AUG.1.2016 // Reuters
Theranos says "will be working with academic institutions and other independent parties to validate and publish our results."

Theranos CEO, In Philadelphia To Appeal To Scientific Community, Tries To Stop The Bleeding
AUG.1.2016 // CBS Philly
It’s been a bruising journey for Theranos, the Silicon Valley blood-testing startup once valued at $9 billion.

Theranos Tries to Quell Doubts With New Blood Test Platform, but Shows Scant Data
AUG.1.2016 // STAT
A long-awaited scientific presentation by Theranos CEO Elizabeth Holmes on Monday amounted to a plea and a promise: Forget the past. We’ll redeem ourselves soon.

A key test for Theranos CEO: Convincing the experts
AUG.1.2016 // CNBC
Elizabeth Holmes, the young CEO of blood-testing start-up Theranos, has had a standing invitation for the past few years to present at the annual summit for laboratory medicine, the conference of the American Association for Clinical Chemistry.

Theranos' Hail Mary pass: A tabletop laboratory
AUG.1.2016 // CNN
Today, the controversial biotech startup Theranos will go where it has never been before: a scientific conference.

Embattled Theranos chief plans to reveal science behind ‘groundbreaking’ technology, amid skepticism
AUG.1.2016 // The Washington Post
The Silicon Valley startup has said chief executive Elizabeth Holmes will finally pull back the curtain on its science on Monday afternoon at the annual meeting of the American Association for Clinical Chemistry in Philadelphia.

Theranos has a lot to prove when it presents data on its blood tests — here's what to expect
AUG.1.2016 // Business Insider
On Monday afternoon, Theranos CEO Elizabeth Holmes will have a chance at some redemption. She is presenting data on the company's controversial "revolutionary" tests that take only a finger-prick's worth of blood.

Philly swings from Dems to Chems, as the DNC ends and a chemists' confab begins
JUL.31.2016 // Philly.com
On Monday afternoon, Theranos CEO Elizabeth Holmes will have a chance at some redemption. She is presenting data on the company's controversial "revolutionary" tests that take only a finger-prick's worth of blood.

Theranos’ Elizabeth Holmes to Face 1,000 Scientists Monday
JUL.29.2016 // KQED
Holmes will present, for the first time and in front of hundreds of lab experts, “reproducibility and correlation data” for the blood-testing technology her company claims to have developed but has never proven to the satisfaction of the scientific community.

Theranos Advisor Says Embattled Company Has 'Exciting Future Ahead'
JUL.19.2016 // Fortune
Blood testing company Theranos may be under federal investigation and its CEO banned from operating a lab for two years, but it still has at least one believer.

Under Fire, Theranos CEO Stifled Bad News
JUL.10.2016 // Wall Street Journal
Shortly after the new advisory board’s appointment, Ms. Holmes accepted an invitation to present Theranos’s fingerprick-testing technology and clinical data at the American Association for Clinical Chemistry’s annual meeting on Aug. 1 in Philadelphia.

Challenges Loom for Point-of-Care Diagnostics
JUL.5.2016 // GEN
The Cube is a PCR-based platform designed to go from sample to result in 30 minutes. The Cube will be launched next month at the American Association of Clinical Chemistry (AACC) meeting in Philadelphia, and made available for purchase soon after.

Theranos faces congressional inquiry over faulty blood tests
JUL.5.2016 // Tech Crunch
Theranos says it looks forward to clearing things up for these lawmakers. “Patient safety and clinical quality are our top priorities,” Theranos said in a statement.

We Can Improve At-Home Lab Tests
JUN.28.2016 // U.S. News and World Report
Only 12 percent of American adults have proficient health literacy. The situation may be worse for lab tests, since there is a general lack of awareness of their limitations. In light of the inevitability of more testing like this, professional societies, such as the American Association for Clinical Chemistry, have issued recent position statements on this topic.

Theranos Says It Will Share Blood-Test Information in August
JUN.20.2016 // Managed Care Magazine
An abstract released by the AACC indicates that Holmes will present data on how the finger-prick test works and how it compares with standard blood-draw tests.

Something May Be Working At Theranos, But You Don't Know What It Is
JUN.17.2016 // Forbes
Holmes is going to be presenting some information at the annual meeting of the American Association for Clinical Chemistry in August, but it still won’t be a normal scientific presentation that is peer-reviewed ahead of time.

Theranos Promises to Share Its Research in August
JUN.16.2016 // Inc.
But when Elizabeth Holmes, Theranos' founder and CEO, speaks at the annual meeting of the American Association of Clinical Chemistry this August, she may actually face a somewhat sympathetic audience, says Dr. Patricia Jones, the president of the AACC and the clinical director of chemistry for the Children's Medical Center in Dallas.

Theranos is finally going to share data on its blood tests — here's what to expect
JUN.15.2016 // Business Insider
That's going to be a big deal because Theranos has not publicly shared any data, saying that it'd rather go through the FDA process.

Walgreens gives up on embattled Silicon Valley startup Theranos
JUN.13.2016 // The Washington Post
Holmes this summer will present scientific information about Theranos's technologies at the American Association for Clinical Chemistry's conference — something she has been invited to do at least once in the past and declined, according to AACC President Patricia Jones.

Theranos CEO Elizabeth Holmes takes big gamble at conference
JUN.10.2016 // San Francisco Chronicle
The embattled Theranos founder and CEO, soon to be played by actress Jennifer Lawrence in a movie based on her company’s recent battles, has agreed to present the company’s blood-testing technology at a major medical conference Aug. 1.

This four-inch cube is the world's smallest DNA tester
JUN.4.2016 // Business Insider
The company plans on making the initial “assays,” or scannable test kits, available at the American Association for Clinical Chemistry’s Clinical Lab Expo in Philadelphia on July 31.

Theranos Says Only 1% of Results Affected; Some Doubt Tests
JUN.3.2016 // Bloomberg
Theranos has yet to present peer-reviewed studies showing that its technology works, though it has said it will present some data at the American Association for Clinical Chemistry’s annual meeting, which starts on July 31.

And the self-made women of the year are
JUN.3.2016 // Verily Magazine
Holmes is scheduled to speak at the annual meeting of the American Association for Clinical Chemistry in August and so far appears ready to defend herself.

Elizabeth Holmes, Founder of Theranos, Falls From Highest Perch Off Forbes List
JUN.1.2016 // The New York Times
Ms. Holmes, 32, who has repeatedly vowed to reveal all, is now expected to present some data to the public in August at the annual meeting of the AACC, formerly the American Association for Clinical Chemistry. 

From $4.5 Billion To Nothing: Forbes Revises Estimated Net Worth Of Theranos Founder Elizabeth Holmes
JUN.1.2016 // Forbes
Last year, Elizabeth Holmes topped the Forbes list of America’s Richest Self-Made Women with a net worth of $4.5 billion. Today, Forbes is lowering our estimate of her net worth to nothing.

Why Are Theranos's Scientific Advisers Staying Quiet?
MAY.25.2016 // Inc.
Instead, she said, the next time anyone would hear from Theranos publicly would be on August 1, when Holmes is scheduled to give an address at the annual scientific meeting of the American Association of Clinical Chemistry, in Philadelphia.

Theranos plans bold expansion even as it reels from new setbacks
MAY.19.2016 // STAT
Holmes is slated to unveil some data this summer before the American Association for Clinical Chemistry.

Medical laboratory science grads in Minnesota are well paid and sought after. So why aren't universities producing more of them?
MAY.18.2016 // MinnPost
Nationwide, though MLS education programs produce 6,000 medical laboratory professionals each year, more than 7,000 laboratory jobs become available, according to a report released last November by the American Association for Clinical Chemistry.

Asia’s Scientific Trailblazers: Dennis Lo
MAY.11.2016 // Asian Scientist
Even when faced with setbacks at turning points in his career, Lo persisted in his research, developing non-invasive prenatal diagnostic tests that are now used around the world.

What Everyone Should Know About Lab Tests
MAY.09.2016 // Scientific American
A new study estimates that in the United States, some 251,000 deaths per year occur because of errors in medical care.

Theranos Director Defends CEO, Says Investors Have Faith
APR.19.2016 // Bloomberg
Theranos Inc. board member David Boies defended Chief Executive Officer Elizabeth Holmes on Tuesday, saying she has the management and scientific skills to lead the blood-testing startup despite criminal and civil investigations of the company by U.S. authorities.

Theranos is planning on doing something this summer it's never done before
APR.19.2016 // Business Insider
One of the biggest criticisms of controversial blood-testing startup Theranos has been simple: Where's the data? But now we may finally know — at least as soon as this summer.

When does hyping a product become a criminal act? Theranos may be about to find out
APR.19.2016 // STAT
When does hype cross the line into illegal activity? That’s the big question animating criminal and civil probes into Theranos, the once high-flying Silicon Valley startup that aimed to revolutionize medical testing by developing technology that could perform an array of lab tests with just a few drops of blood.

Elizabeth Holmes to Present Theranos Data at Scientific Conference
APR.18.2016 // KQED
In what is sure to be a hot ticket this summer, Elizabeth Holmes is going to present data on Theranos’ technology at a meeting of scientists well-equipped to judge its validity.

Elizabeth Holmes to finally unveil Theranos data in August — if she lasts
APR.18.2016 // MedCity News
Holmes plans on finally pulling back the veil on the company’s “nanotainers,” its Edison device and other proprietary research in August at the American Association for Clinical Chemistry‘s annual scientific meeting.

Theranos Founder Elizabeth Holmes Is Facing a Ban by Regulators
APR.13.2016 // Fortune
Theranos founder and CEO Elizabeth Holmes may be forced out of her company after federal regulators proposed banning her for at least two years after she didn’t fix major problems at its California laboratory.

Changes Are Coming: What You Need to Know About Laboratory Developed Tests
APR.13.2016 // Laboratory Equipment
Although regulated, laboratory developed tests have enjoyed less oversight than other FDA products for the most part—but that’s all about to change.

Should Consumers Be Allowed to Order Their Own Lab Tests?
APR.10.2016 // Wall Street Journal
There is plenty of information available to assist people in monitoring their own health. Lab Tests Online, for example, was developed by lab professionals to help patients and providers navigate the nuances of testing.

Power Sheet - April 8, 2016
APR.08.2016 // Fortune
Elizabeth Holmes's company announced it's adding six members to its medical board, five of whom have served as president or board members of the American Association for Clinical Chemistry.

Theranos bolsters scientific board after independent technology review
APR.08.2016 // Fierce Medical Devices
Now, following independent scientific review of its contentious technology, the Palo Alto, CA-based upstart has boosted the ranks of its scientific advisory board.

The Broadsheet: April 8th
APR.08.2016 // Yahoo News
Speaking of Elizabeth Holmes: Theranos, her troubled blood-testing startup, announced that it has assembled what Fortune's Roger Parloff calls "a startlingly well-qualified medical advisory board." Former president of the American Association For Clinical Chemistry Susan Evans and Ann Gronowski of the Washington University School of Medicine are among the members.

Theranos Expands Scientific Board; CEO Says Data Will Be Shared
APR.07.2016 // Bloomberg
Theranos Inc., the blood-testing startup facing regulatory scrutiny, added physicians from prominent hospitals to its scientific and medical advisory board in a push to help persuade skeptics that the secretive company’s technology is viable.

Theranos Adds Startlingly Well-Qualified Medical Board
APR.07.2016 // Fortune
But it’s unclear precisely what it will do.

Theranos adds a bunch of qualified medical experts and scientists to the board
APR.07.2016 // Tech Crunch
Theranos has taken a pretty damning hit in a string of bad news reports over the past year but it looks like the one drop blood analysis company is trying to turn things around.

Theranos Announces Leading Medical and Laboratory Experts Join Scientific and Medical Advisory Board
APR.07.2016 // NBC12 WWBT
Theranos today announced that nationally respected laboratory and medical experts have joined the company’s Scientific and Medical Advisory Board.

Theranos expands medical advisory board as it awaits word from regulators
APR.07.2016 // Silicon Valley Business Journal
Theranos said on Thursday that it has expanded its scientific and medical advisory board after hosting three scientific review sessions in Palo Alto.

Theranos Beefs Up Board in Light of Lab Problems
APR.07.2016 // Medtech Pulse
Reeling from months of negative press coverage and warnings from CMS and FDA, Theranos is beefing up its scientific and medical advisory board with eight medical and lab testing experts.

More Insurance Companies Now Paying for Fibromyalgia Blood Test
APR.04.2016 // National Pain Report
Do you have a family member, friend or physician who doubts you have fibromyalgia? Well, there’s a little-known test you may not have heard of that could finally prove you’re really sick.

Inaccurate Cholesterol Tests from Theranos
MAR.29.2016 // The Scientist
The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.

Study Raises Questions About Accuracy of Some Theranos Blood Tests
MAR.28.2016 // The Washington Post
A new study has found that the proprietary technology behind the embattled blood-testing startup Theranos was substantially more likely to flag results as abnormally high or low compared with other companies -- a difference that raises concerns about the accuracy of those Theranos tests.

A Top Medical Institution Ran a Secret Study on Theranos — Here's What They Found
MAR.28.2016 // Tech Insider
Medical researchers have finally gone and run the study on blood testing startup Theranos that observers have been waiting for.

Voice, DNA, Fingerprint and Others: How 5 Biometric Security Solutions Compare
MAR.18.2016 // Computer Business Review
At a 2015 American Association for Clinical Chemistry event, researchers presented a low-cost platform to detect chlamydia that integrates sample preparation, DNA amplification and data processing in an instrument the size of a coffee mug.

Is Theranos Too Good To Be True?
FEB.13.2016 // Forbes
Elizabeth Holmes, founder of Theranos, the company valued at approximately $9 billion, with celebrities like Henry Kissinger on its board, has a helluva story.

Endocrine Society Issues New Guidelines for Primary Adrenal Insufficiency
FEB.03.2016 // MD Magazine
The Endocrine Society released a new clinical practice guideline covering diagnosis and treatment of primary adrenal insufficiency in January 2016. The European Society of Endocrinology and the American Association for Clinical Chemistry co-sponsored this document.

Riding High: Pot-Smoking Drivers Evade Blood Tests
FEB.03.2016 // Live Science
People who drive after smoking marijuana are at greater risk of car crashes, but blood tests to check for the drug may not be a reliable way to catch impaired drivers, a new study suggests.

Here’s What Theranos Customers Need to Know
FEB.01.2016 // The Verge
A warning letter that the US Centers for Medicare and Medicaid Services sent to Theranos last week could have serious consequences for the blood testing company, which has been valued at $9 billion.

'More Skeptical Than Ever': Experts Respond to the Government's Warning Letter to Theranos
JAN.28.2016 // Tech Insider
Blood testing startup Theranos is under fire.

For Theranos, the Bad News Keeps Coming
JAN.26.2016 // KQED Science
So how much do Theranos employees not look forward to the morning delivery of The Wall Street Journal?

New PAI Guidelines Stress Importance of Treating Adrenal Crisis
JAN.21.2016 // Medscape
The first-ever guidelines from the Endocrine Society on diagnosis and management of primary adrenal insufficiency (PAI) call for the use of the high-dose corticotropin stimulatory test as the gold standard for diagnosis in adults, hydrocortisone as first-line therapy, and urgent treatment of adrenal crisis.

Endocrine Society Issues First-Ever Guidelines for Primary Adrenal Insufficiency
JAN.16.2016 // Clinical Endocrinology News
New guidelines on the diagnosis and management of primary adrenal insufficiency stress the importance of early recognition and the need to prevent life-threatening adrenal crises in these patients.

Emerging Proteomic Technologies: MALDI-TOF for Clinical Protein Quantitation
JAN.15.2016 // GenomeWeb
Asked recently by GenomeWeb what he saw as one of the most interesting emerging proteomic technologies, SISCAPA Assay Technology CEO Leigh Anderson highlighted TOF-based quantitation, in particular MALDI-TOF-based quantitation.

JP Morgan Healthcare Day Three: Foundation Med; Cepheid; BD; Invitae; GenMark; Berry Genomics
JAN.14.2016 // GenomeWeb
The 34th Annual JP Morgan Healthcare Conference entered its third day here Wednesday with several life science research tools and diagnostic firms making presentations to investors and other attendees.

Julie Coker Graham Named President/CEO of Philadelphia Convention & Visitors Bureau
JAN.07.2016 // Trade Show News Network (TSNN) Blog
Julie Coker Graham officially stepped into her new role Jan. 1 as the president and CEO of the Philadelphia Convention & Visitors Bureau (PHLCVB).

VTE Guide Shifts Emphasis to NOACs
JAN.07.2016 // MedPage Today
The newer oral anticoagulants (NOACs) are now recommended over vitamin K antagonists such as warfarin for initial and long-term treatment of venous thromboembolism (VTE) in updated CHEST guidelines.

The Theranos Scandal Should Be a Wake-Up Call. Here Are 4 Reasons It Won’t Be
DEC.30.2015 // STAT
Not even the holiday slowdown could bring a reprieve for the beleaguered blood-testing company Theranos.

Theranos’ Proprietary Tech Wasn’t Vetted by Federal Inspectors for Two Years
DEC.30.2015 // The Verge
Theranos, the Silicon Valley blood testing company, launched its first blood-sampling center at the end of 2013. But for most of the two years that followed, federal officials didn’t inspect Theranos’ inventions at all, The Verge has learned.

Can Elizabeth Holmes Save Her Unicorn?
DEC.10.2015 // Bloomberg Businessweek
“Typically companies will show their product at a professional meeting, talk about it, their scientist will present data. Theranos has chosen not to do that, which in my mind is dubious,” says David Koch, president of the American Association for Clinical Chemistry and a professor at Emory University.

Brunswick Mom Donates Part of Liver to Save Infant Son
DEC.7.2015 // The Medina-Gazette
During an INR blood-clotting test, Brodie scored a 9+. The average score is 0.9 to 1.1, according to the American Association for Clinical Chemistry.

How to Optimize Antidiabetic Pharmacotherapy Using the Clinical Significance of HbA1c Variations
NOV.20.2015 // Diabetes in Control
The American Association for Clinical Chemistry recently held a free, informative webinar about HbA1c.

Roche Rapid Flu MDx Test Shown to Impact Patient Care in ER
NOV.5.2015 // Genome Web
Roche's Cobas Liat molecular flu assay is a rapid, adaptable, and sensitive assay that can impact patient care in the emergency room setting.

Here's Why the Jury Is Still Out on Theranos
OCT.27.2015 // Tech Insider
Medical diagnostic and blood testing company Theranos has had a rough couple of weeks, and people want to know how things are going to shake out.

FDA Inspector Slams Theranos for Poor Quality Management
OCT.27.2015 // The Verge
The US Food and Drug Administration today issued two reports, both of a type called a Form 483, which documented the problems the agency found at Theranos, the notoriously secretive blood testing company.

Theranos Doesn’t Want Its Tech Compared to Other Machines — Except When It’s Convenient
OCT.23.2015 // The Verge
Theranos, the hot Silicon Valley blood testing company that’s now under scrutiny after a blockbuster Wall Street Journal article, replied with 6,000 words yesterday claiming that the Journal got their reporting wrong.

This Isn't the First Time People Have Raised Troubling Questions About Theranos
OCT.16.2015 // Business Insider Australia
Faster, cheaper, better. An innovation that accomplishes those three things has the potential to disrupt an industry. But such innovations are rare.

Here's What We Know About How Theranos' 'Revolutionary' Technology Works
OCT.16.2015 // Tech Insider
On October 15, an investigative report by The Wall Street Journal said that hot startup Theranos, founded by Elizabeth Holmes, was mostly relying on traditional technology to analyze blood-test results.

This Isn't the First Time People Have Raised Troubling Questions About Theranos
OCT.15.2015 // Tech Insider
Faster, cheaper, better. An innovation that accomplishes those three things has the potential to disrupt an industry. But such innovations are rare.

From the Editor: Make No Mistake
OCT.12.2015 // Clinical Lab Products
Pathology and laboratory medicine organizations wasted little time before responding to the recent publication by the Institute of Medicine (now a unit of the National Academy of Medicine) on the subject of diagnostic errors.

People in the News: Michael Bennett, David Teitel, and More
OCT.09.2015 // Genome Web
The American Association for Clinical Chemistry announced that Michael Bennett has been elected president-elect.

Hair Follicle Drug Tests Can Lead To A False Positive, Thanks To Secondhand Traces Of Marijuana
OCT.09.2015 // Medical Daily
Though sometimes hair tests are used in the United States, the American Association for Clinical Chemistry suggests that urine tests are the most frequently used drug screens.

New Blood Test Is 99.6% Accurate, Safely Identifies Patients At Low Risk Of Heart Attack
OCT.08.2015 // Medical Daily
A high troponin level or even slight elevation can indicate injury to the heart, according to the American Association for Clinical Chemistry.

AACC Urges CMS to Delay Enforcing Glucose Monitor Regulations
OCT.01.2015 // Medical Laboratory Observer
The American Association for Clinical Chemistry (AACC) has sent a formal comment letter to the Centers for Medicare and Medicaid Services (CMS) addressing CMS’ proposal to enforce more stringent regulatory requirements for in-patient and outpatient hospital testing with blood glucose monitors.

Clinical Laboratories and the Future of Antimicrobials
SEP.29.2015 // USA Today: Future of Personal Health
Using the latest diagnostic tests, clinical laboratory professionals enable doctors to determine whether antibiotics are needed, and choose the right ones for optimal patient outcomes.

Podcast: David Koch and Rebecca Cooney Discuss the IOM Report on Diagnostic Errors
SEP.28.2015 // The Lancet
Improving the quality of care is a constant challenge in American health, and one previously underappreciated area of patient safety is how we assess and reduce the number of diagnostic errors.

Fear of Overtesting and Malpractice Often Drives Diagnostic Errors
SEP.28.2015 // Fierce Healthcare
One reason for the widespread problem of diagnostic errors is the pressure clinicians are under to avoid unnecessary tests and control healthcare costs, according to a leading healthcare expert who was one of the reviewers of the recent Institute of Medicine (IOM) report that revealed most people will experience a misdiagnosis at some point in their lives.

Medical Labs Can Help Prevent Diagnostic Errors
SEP.27.2015 // The Washington Post
The Sept. 23 news article “Study: Most Americans will get at least one wrong diagnosis,” about a recent report from the Institute of Medicine, highlighted the danger and costs that every patient faces.

Landmark Report Urges Reform to Avert Diagnostic Errors
SEP.22.2015 // Medscape
Authors of a landmark report find that little progress has been made in reducing diagnostic errors in the 15 years since the Institute of Medicine's (IOM) report To Err is Human: Building A Safer Health System revealed dramatic lapses in patient safety.

What Are the Different Types of Cholesterol: Which One Is Bad?
SEP.17.2015 // Healthline
Although cholesterol is a naturally occurring substance that’s needed to build healthy cells in the body and keep it functioning properly, too much cholesterol can increase your risk of cardiovascular disease.

Beckman Coulter Diagnostics Receives 2015 Scientists' Choice Award for Best New Clinical Laboratory Product
SEP.11.2015 // Advance
Beckman Coulter Diagnostics' automated Access AntiMüllerian Hormone (AMH) assay was recently selected as the Best New Clinical Laboratory Product of 2014 for the 2015 Scientists' Choice Award by members of SelectScience.

New Diagnostic Tests Serve the Underserved
SEP.10.2015 // Laboratory Equipment
Newly developed point-of-care clinical tests are faster and more affordable, bringing heath care to the masses.

Atlanta Hotels Reach Record Occupancy Numbers in July
AUG.18.2015 // Atlanta Sun Times
Atlanta hotels put up fire-cracking numbers in July, reaching 80 percent occupancy within city limits, according to recent data by the Atlanta Convention & Visitors Bureau.

That’s a Wrap, AACC 2015
AUG.11.2015 // CLP Magazine
The 2015 annual meeting of the American Association for Clinical Chemistry (AACC) saw more than 400 educational sessions, more than 720 exhibitors, and attendance by more than 17,500 medical professionals and healthcare leaders.

New Smartphone DNA Test for Chlamydia is Fast, Inexpensive
AUG.06.2015 // Consultant360
A novel smartphone test that can detect chlamydia with high accuracy could reduce the cost and burden of screening for this highly prevalent sexually transmitted disease, according to new data presented last week at the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo in Atlanta.

The Lab Test That Can Do It All
AUG.01.2015 // Daily Rx News
Small labs and clinics in low-income areas often can’t afford state-of-the-art technology, but that might be about to change.

To meet TAT goals, Vanderbilt builds ED lab
AUG.2015 // CAP Today
In a move expected to help meet accreditation standards on testing turnaround times for stroke and chest pain patients, Vanderbilt University Medical Center’s emergency department will gets its own satellite laboratory this month.

First Point-of-Care Device for Routine Clinical Testing
JUL.31.2015 // American Laboratory
A first-of-its-kind point-of-care device can perform routine laboratory tests, examine cholesterol levels to screen for risk of heart disease, and screen for bleeding/monitor treatment for inappropriate blood clotting, and provides results in 3‒10 minutes.

First smartphone DNA test for chlamydia developed
JUL.30.2015 // Business Standard
Researchers have developed a first-of-its-kind smartphone test for chlamydia that can detect the sexually transmitted disease (STD) with high accuracy and is easier and cheaper than current diagnostic methods.

SMARTPHONE DNA TEST FOR CHLAMYDIA DEVELOPED
JUL.30.2015 // Sakshipost
Researchers have developed a first-of-its-kind smartphone test for chlamydia that can detect the sexually transmitted disease (STD) with high accuracy and is easier and cheaper than current diagnostic methods.

Chlamydia screening 'easier and cheaper' with new DNA smartphone test
JUL.30.2015 // Medical News Today
Researchers have created a simple smartphone DNA test that they say can accurately detect chlamydia - the most commonly reported sexually transmitted infection in the US.

First smartphone DNA test for chlamydia developed
JUL.30.2015 // The Economic Times
Researchers have developed a first-of-its-kind smartphone test for chlamydia that can detect the sexually transmitted disease (STD) with high accuracy and is easier and cheaper than current diagnostic methods.

First smartphone DNA test for chlamydia developed
JUL.30.2015 // Lab Medica
Expanded Steroid Control has been launched that now contains nine analytes of interest at clinically relevant levels for mass spectrometry and separation science technology.

Randox woos new customers by hosting workshop in US
JUL.29.2015 // Belfast Telegraph
Northern Ireland medical testing firm Randox has said it hopes to gain new customers as it takes part in the world's largest medical conference in the US.

Indian diagnostics outfit debuts 'lab-on-cartridge' device for developing countries
JUL.29.2015 // Fierce Medical Devices
As the med tech industry homes in on rapid, point-of-care diagnostics geared toward low-income countries, an Indian diagnostics company is developing a "lab-on-cartridge" device that uses inexpensive technology to quickly scan for a host of diseases and conditions.

AACC 2015: New Mobile DNA Test for Chlamydia Announced
JUL.29.2015 // Bioscience Technology
A team of researchers led by Dr. Jeff Tza-Huei Wang from the Johns Hopkins University BioMEMS lab created a new smartphone DNA test capable of diagnosing chlamydia with high accuracy.

Johns Hopkins Researchers Develop Handheld Chlamydia Test Using Microfluidics, Smartphone
JUL.29.2015 // Genome Web
Biomedical engineers at Johns Hopkins University have developed a microfluidic device to enable inexpensive point-of-care molecular testing.

Smartphone DNA Test For Chlamydia Offers Affordable Alternative
JUL.29.2015 // Tech News
Chlamydia is somewhat of a silent STD — most people who are infected are not even aware of it. But if left untreated, it can cause permanent damage.

American Association for Clinical Chemistry: AACC panel says more diagnostics are getting smaller, implantable
JUL.28.2015 // Medical Device Daily
Diagnostics are changing. More sensor-based technologies that can be implanted in the body are emerging and with the addition of an algorithm, smartphones are becoming accurate diagnostic devices.

Hair May Shed Light on Link Between Asthma, Cortisol, Pregnancy Complications
JUL.28.2015 // Laboratory Equipment
Hair samples can be used to measure the effects of asthma on the cortisol levels of women during pregnancy, according to research presented today at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta. This research also shows that levels of cortisol, a stress-related hormone, tend to be lower among pregnant women with asthma than among pregnant women without the chronic, inflammatory lung disease.

Fingernail Tests May Offer Cheap, Simple Way to Diagnose Diabetes
JUL.28.2015 // American Journal of Managed Care
A simple test of fingernail clippings could replace a blood draw as a way to diagnose and monitor type 2 diabetes mellitus (T2DM), with huge implications for tracking the disease the developing world.

AACC 2015: New Tests Could Make Diagnosing Diabetes Easier
JUL.28.2015 // Bioscience Technology
Two new research studies presented at the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting and Lab Expo, show promise for quicker and less-expensive ways to detect diabetes.

Research on rapid Ebola test presented at AACC gathering
JUL.28.2015 // BioPrep Watch
Research that was presented at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition that will expand on a study that procured the rapid test for the Ebola virus, the ACCC announced Monday.

Intelligent Walkaway Clinical Chemistry Analyzer Showcased at AACC
JUL.27.2015 // Lab Medica
A global provider of hematology and clinical chemistry analyzers will display its new economic walkaway clinical chemistry analyzer at the 2015 annual meeting of the American Association of Clinical Chemistry (AACC; Washington DC, USA) in Atlanta (GA, USA) during July 28–30, 2015, in booth 2100.

New Ebola Test Gives Current Gold Standard a Run for Its Money
JUL.27.2015 // MD Magazine
In just 15 minutes an Ebola fingerstick blood test can accurately determine whether a patient is infected with the virus, a team from the Viral Hemorrhagic Fever Consortium reported.

American Association for Clinical Chemistry (AACC) 2015 Annual Meeting & Clinical Lab Expo
JUL.27.2015 // Bioscience Technology
AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare.

Cepheid readies for 2016 launch of point-of-care molecular Dx system for use anywhere
JUL.27.2015 // Fierce Medical Devices
Diagnostics are not just breaking out of the lab. Now they're about to be available anywhere the patient is with a new device from Cepheid ($CPHD) that it says is the first point-of-care diagnostic device intended for such a broadly defined area of use.

AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
JUL.27.2015 // Fierce Medical Devices
In a new position statement on direct-to-consumer (DTC) laboratory testing, the American Association for Clinical Chemistry (AACC; Washington DC, USA) emphasizes the need for patient-friendly reports and for sufficient transparency about quality of tests and results.

EKF Diagnostics launches new clinical chemistry analyzer at AACC 2015
JUL.23.2015 // News Medical
EKF Diagnostics, the global in vitro diagnostics company, announces the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga, 26-30 July.

The Tech World’s Blood-Test Darling Gets Nods From the FDA
JUL.21.2015 // Wired
The blood test is a cornerstone of modern medicine. In many cases, it provides evidence that turns a bundle of symptoms to a treatable diagnosis. It’s also inconvenient at best, painful at worst, and expensive.

FDA Approves Finger Prick Blood Tests Patients Can Do Without A Lab
JUL.21.2015 // CBS SF Bay Area
Blood tests usually require a prescription, a trip to a lab, hypodermic needles, vials of blood, and a followup visit to the doctor’s office to get the results.

Super-cheap origami disease-testing kit can be printed on demand
JUL.17.2015 // New Scientist
Think of it as origami that could save your life. A sheet of paper can be turned into a personalised diagnostic toolkit using nothing more than an inkjet printer and a few well-placed folds.

Panel Recommends Improvements in Estrogen Testing Accuracy
JUL.16.2015 // MedicalResearch.com
Accurate data on estrogen levels are needed to ensure appropriate and effective patient care.

From the Editor: More Where That Came From
JUL.13.2015 // Clinical Lab Products
Starting with a discussion about AACC’s recent position statement on the role of labs in personalized and precision medicine, Valdes goes on to show just how wide-ranging these trends have become.

Inside Track: Labs Claim a Personal Stake
JUL.10.2015 // Clinical Lab Products
Clinical laboratorians have long recognized the importance of laboratory medicine for guiding decisions related to patient care.

Theranos to partner with Capital BlueCross to provide DTC testing
JUL.9.2015 // Healthcare Dive
Elizabeth Holmes' blood tests have been hailed as great disruptors to healthcare and use continues to expand—although this year she has begun to face some, if not outright criticism, questions.

Mid Cap Stocks To Watch For: TCF Financial Corporation (NYSE:TCB), Cepheid (NASDAQ:CPHD), LendingClub Corp (NYSE:LC), Health Net, Inc. (NYSE:HNT)
JUL.3.2015 // Wall Street Observer
Cepheid (NASDAQ:CPHD) declined -5.05% to end last trading session at $58.04. The company, on June 09, 2015, reported that the company will host a Financial Analyst Event on Monday, July 27th at the 2015 AACC Meeting being held July 26th to 30th in Atlanta, GA.

You may want to touch these 8 adorable looking creatures but beware once you touch them you are dead for sure...
JUL.2.2015 // Moviepilot
According to the toxin library of the American Association of Clinical Chemistry (AACC), this is no simple sting: Intense throbbing pain develops within five minutes of contact, with pain extending up the affected arm.

AACC Calls for Coverage, Reimbursement of Companion Diagnostics
JUN.23.2015 // G2 Intelligence
With “precision medicine” and “personalized medicine” initiatives in the spotlight, the American Association for Clinical Chemistry (AACC) is looking to seize the momentum with a call for policies that ensure access to and appropriate reimbursement for tests that enable tailored treatment.

AACC urges development of and coverage for innovative personalized medicine lab tests
JUN.18.2015 // MLO Online
The American Association for Clinical Chemistry (AACC) has released a position statement endorsing efforts within the healthcare community to improve patient outcomes by personalizing medical care.

AACC recruiting for editor-in-chief of new journal: The Journal of Applied Laboratory Medicine
JUN.18.2015 // Talking New Media
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is seeking applications for editor-in-chief of a new journal: The Journal of Applied Laboratory Medicine: An AACC Publication.

Estrogen testing accuracy improvements recommended
JUN.13.2015 // Healio
New recommendations were recently released that call for accurate, standardized estrogen testing methods to help improve patient care, according to a statement published in The Journal of Clinical Endocrinology & Metabolism.

Elizabeth Holmes still won't explain how her $9 billion technology actually works
JUN.6.2015 // Business Insider
On June 3, Elizabeth Holmes, the founder and CEO of Theranos, a company that developed a revolutionary blood test that relies only on a drop of blood, appeared on Charlie Rose‘s show to talk about her company and in theory, about some of the science behind it.

The Medical Minute: How Does Alcohol Affect THC Blood Concentration?
JUN.3.2015 // Leafly
If you’re the type of person who likes having a beer in one hand and a joint in the other, you may be interested in this new study from the American Association of Clinical Chemistry (AACC), which found that THC blood concentrations increase significantly with alcohol consumption.

Association Departures and Arrivals (May 29, 2015)
MAY.29.2015 // CEO Update
Lauren Kramer has joined the $18M-revnue American Association for Clinical Chemistry as vice president of education and meetings. She previously was the director of meetings at the International Council of Ophthalmology.

Stoned? Booze Dramatically Increases Your High
MAY.28.2015 // Newser
Marijuana and alcohol are one of the most common drug combinations implicated in car accidents, so researchers at the National Institute on Drug Abuse recently set out to better understand how the two interact.

Marijuana: Cannabis Plus Alcohol Makes for More Dangerous High
MAY.27.2015 // Nature World News
Despite the increased legalization of marijuana, many people are still skeptical of its adverse effects on users.

New Malaria Test Effective for Large-Scale Screening
MAY.20.2015 // Healio
A novel method for malaria testing could achieve large-scale screening and cost-effectiveness that is vital to successful disease control, according to research published in Clinical Chemistry.

Washington-Area Appointments and Promotions for May 18
MAY.17.2015 // The Washington Post
American Association for Clinical Chemistry of the District appointed Lauren Kramer vice president of education and meetings.

New Malaria Test Could Lead to Global Eradication
MAY.13.2015 // Iowa Ag Connection
One of the biggest difficulties faced by worldwide programs aimed at eliminating malaria is that the tests they use are not sensitive enough to detect all people who have the disease and need treatment.

New Malaria Test Could Lead to Global Eradication of the Disease
MAY.12.2015 // Post Online Media
A study appearing online in Clinical Chemistry, the journal of AACC, shows that a new test known as capture and ligation probe-PCR (CLIP-PCR) could diagnose the malaria cases that would typically escape detection and lead to new infections.

At Virology Meeting, Quidel Gives Update on Solana MDx Platform; Researchers Share Data on AmpliVue
APR.29.2015 // GenomeWeb
Clinical diagnostics firm Quidel described improvements it has made to its Solana molecular testing platform, and outlined future menu goals and possible platform improvements during a company-sponsored corporate workshop at the Clinical Virology Symposium here this week.

TS Picks: April 29, 2015
APR.29.2015 // The Scientist
Theranos Chief Executive Officer Elizabeth Holmes has for years touted the promise of her firm’s blood-based diagnostic technology, raising millions of dollars to roll it out on a large scale.

Pharmalot.. Pharmalittle.. Good Morning: We’re Catching Up on Mylan, Teva, Rx Prices, and Lots More!!
APR.27.2015 // The Wall Street Journal
The Theranos blood test could upend the branch of medicine that provides the data used in roughly 70% of medical decisions, but questions remain about how disruptive it may really be because no one knows how it works.

Scientists Are Skeptical About the Secret Blood Test That Has Made Elizabeth Holmes a Billionaire
APR.25.2015 // Business Insider
Theranos, a company founded by Stanford sophomore Elizabeth Holmes in the fall of 2003 (she dropped out a few months later) has generated a lot of buzz for developing a revolutionary approach to the blood test.

Holy Family Memorial Lab Critical to Patient Diagnoses
APR.23.2015 // HTR News
Visit a hospital and you'll likely see nurses checking blood pressure, doctors prescribing medicine or even technicians taking X-rays. But not many see the medical laboratory professionals who are busy analyzing samples from patients that help detect diseases.

Theranos Revolutionizes Preventative Blood Testing So No One Has To Say Goodbye Too Soon
APR.12.2015 // EmpowHER
Imagine a world where people have control over their own health, a place where early detection doesn’t happen accidentally.

Lab Stakeholders Urge CMS Oversight of NGS Tests as FDA Ponders New Reg Scheme
APR.6.2015 // Health Policy News Stand
Key clinical laboratory stakeholders, weighing in on FDA's potential approach to next generation sequencing (NGS) tests, suggest that CMS, as well as CLIA-recognized accrediting bodies and societies, should continue leading the oversight and guidance for NGS testing in most situations.

Startup Aims for Faster Blood Tests
MAR.29.2015 // Arkansas Online
Springdale firm has pregnancy tool approved in U.S.

Online Self Diagnosis: Are You a “Cyberchondriac”?
MAR.23.2015 // The International Post Magazine
Many of us have used the internet at least once to investigate symptoms in order to pin-point a diagnosis of our illness.

AACC Expresses Concerns to FDA Regarding Overregulation of Next-Generation Sequencing Tests
MAR.20.2015 // Healio
The American Association for Clinical Chemistry wrote a formal request letter to the FDA expressing concern about the potential overregulation of next-generation sequencing tests.

Why Routine Blood Tests Often Fail to Detect Low Thyroid Function (And What We Can Do About It)
MAR.10.2015 // Huffington Post
All too often the routine blood tests fail to detect a significant percentage of low thyroid cases.

"Liquid Biopsies" Could Revolutionize Cancer Detection
FEB.28.2015 // Milwaukee Journal Sentinel
In the next year or two, doctors will begin routinely monitoring cancer using a potentially revolutionary technique that searches for a genetic signature in a blood sample, according to experts in the field.

Scientist Convention Steps Aside to Make Way for DNC in 2016
FEB.13.2015 // Philadelphia Business Journal
The American Association for Clinical Chemistry is going to have to find a new time to hold its annual meeting in 2016.

What They're Saying About Philly's DNC Win in New York, Columbus
FEB.13.2015 // Philadelphia Business Journal
In central Ohio, the Columbus Dispatch said the DNC's decision was "deeply disappointing"and that officials there "panned Philadelphia's chances because of labor strife and the fact that the city already had a convention with 18,000 people scheduled for the same time."

AACC to FDA: Don’t Regulate LDTs to Death
FEB.2.2015 // FDA News
The American Association for Clinical Chemistry said Thursday that it shares the FDA’s goal of improving the safety and efficacy of laboratory-developed tests, but that the agency should limit its oversight to higher-risk LDTs that could pose a serious risk to patients if inaccurate.

Doctors Ordering Wrong Vitamin D Test
JAN.29.2015 // HCP Live
When it comes to ordering the correct test for vitamin D, too many doctors just can't get it right, a new study found.

Washington-area appointments and promotions for Jan. 26
JAN.25.2015 // The Washington Post
American Association for Clinical Chemistry of the District appointed Loretta Doan vice president of policy and global affairs.

Association Departures and Arrivals (January 23, 2014)
JAN.23.2015 // CEO Update
The $18M-revenue American Association for Clinical Chemistry has hired Loretta Doan as VP of policy and global affairs, effective Jan. 14.

Will "Liquid Biopsies" Replace Invasive Tissue Biopsies?
JAN.10.2015 // Med Device Online
Using cell-free DNA found in the blood stream, a team led by Vanderbilt researchers has developed a highly accurate method for detecting prostate cancer.

At Workshop, Labs Tell FDA to Let Them Tweak LDTs; Give Their Take on Labeling and Clinical Validity
JAN.9.2015 // GenomeWeb
"The proposal we issued a few months ago, is just that. It's a proposal," Jeff Shuren, director of the US Food and Drug Administration's Center for Devices and Radiological Health, said yesterday at the start of a two-day workshop to discuss the agency's draft guidance on regulation of laboratory-developed tests (LDTs).

Researchers Develop New Blood Test For Prostate Cancer Detection
JAN.9.2015 // Prostate Cancer News Today
A team of international researchers has identified a method that can detect cell-free tumor DNA in a patient’s bloodstream.

Unprescribed Medical Tests Are Themselves a Sign of Trouble
JAN.8.2015 // LA Times
Long Beach resident David Eckhous told me the other day about his mother's experience with an Ohio company called Life Line Screening, which offers unprescribed medical tests that "can help detect hidden health issues before they become a problem."

Nevada commission: Jon Jones tests results show no signs of doping
JAN.8.2015 // Yahoo Sports
Several prominent anti-doping experts publicly suspected UFC light heavyweight champion Jon Jones of using synthetic testosterone after results of a drug test made public earlier this week showed what seemed to be an abnormally low testosterone-to-epitestosterone (T/E) ratio.

Chronix Team Publishes Validation Study of NGS-based Liquid Biopsy Test
JAN.7.2015 // GenomeWeb
Chronix Biomedical has published a clinical validation study of a next-generation sequencing-based test that analyzes circulating cell-free DNA to gauge whether the patient is at high risk for prostate cancer and should go on to receive a biopsy.

Potential Prostate Cancer Blood Test
JAN.7.2015 // Health Canal
Vanderbilt University researcher William Mitchell, MD, PhD, and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

Italian Team Shows Method for Gene-Expression Profiling of CTCs is Technically Valid, Reliable
JAN.6.2015 // GenomeWeb
A team from the Foundation IRCCS National Cancer Institute in Milan has published a proof of concept of a method for capturing and measuring gene expression in circulating tumor cells, which they hope to use in the clinical care of advanced tumors.

'Liquid Biopsy' Promises to Transform Cancer Screening
JAN.5.2015 // Newsmax Health
An international team of scientists led by Vanderbilt University researchers has devised a new method for detecting "cell-free" tumor DNA in the bloodstream of prostate cancer patients — pointing the way toward development of a “liquid biopsy” that could transform cancer screening.

Watching and Waiting for Codes and Fees
JAN.5.2015 // GEN
Clinical laboratories will be watching and waiting in the new year for the Centers for Medicare and Medicaid Services (CMS) to resolve several unsettled issues concerning fees for molecular pathology tests, as well as coding for drug-screening tests.

AACC Offers Certificate Programs in Laboratory Management
DEC.27.2014 // Advance
AACC's Online Certificate Programs offer six self-paced, educational on-demand courses designed for laboratory management.

Exome Tests Miss Pathogenic Variants in ACMG Recommended Genes
DEC.2.2014 // GenomeWeb
Exome sequencing tests may not cover completely all medically relevant genes and may miss pathogenic variants in disease genes, researchers from the University of Texas Southwestern Medical Center and Thomas Jefferson University reported recently in a study in Clinical Chemistry.

Opponents of FDA's LDT Regulations Lawyer Up, Get in Combat Mode
NOV.26.2014 // Fierce Medical Devices
When the FDA finally released its draft guidance on the oversight of lab-developed tests (LDTs) in July, it ended a 10-plus-year saga to mark its regulatory stamp in that arena, but created a new one over the guidance's implementation.

LDT Battle Lines Drawn: FDA Announces Jan. 8-9 Public Meeting on LDT Framework; Lab and Medical Groups Send Letter to FDA Commissioner Urging Notice-and-Comment Rulemaking; FDA and Patient Groups Advocate for LDT Framework on Hill
NOV.24.2014 // FDA Law Blog
A battle is brewing between proponents and opponents of FDA’s plans to actively regulate Laboratory-Developed Tests (LDTs), with several developments involving both camps in the past two weeks.

Texas Section of the American Association of Clinical Chemistry Hosts All-Star Line-up of Clinical Laboratory Experts to Share Successes at Improving Lab Test Utilization
NOV.17.2014 // Dark Daily
Changes now happening to healthcare and the practice of medical laboratory medicine were upfront and personal here during last Friday’s meeting of the Texas Section of the American Association of Clinical Chemistry (AACC).

POCTs Will Accelerate Sexually Transmitted Disease Diagnoses
OCT.31.2014 // European Hospital
About 350 million people worldwide suffer uncured but curable sexually transmitted diseases. Accurate point-of-care testing is one of the best ways to identify and treat them.

Dressing Up for Ebola’s Unlikely EU Epidemic
OCT.28.2014 // European Hospital
Unlike some news reports the Ebola virus is not as easily transmitted as influenza or other infections. Still, healthcare and laboratory workers must take precautions to quickly identify those infected and prevent an outbreak.

New Discoveries Advance Ability to Detect HCG Doping in Sport
OCT.27.2014 // LawInSport
Important new peer-reviewed research conducted by Getachew A. Woldemariam and Dr. Anthony W. Butch may help increase the ability to detect athletes who are taking human chorionic gonadotropin (hCG) as a doping substance to enhance athletic performance.

This New Ebola Test Is As Easy As a Pregnancy Test, So Why Aren’t We Using It?
OCT.3.2014 // The Daily Beast
The best weapon against the outbreak may be one we’re not using: Scientists at Tulane University are sitting on millions of rapid diagnostic kits capable of spotting the virus instantly.

Is Your Lab Ready for Ebola?
OCT.3.2014 // SelectScience
Now that the Ebola virus has arrived in the U.S., the ability of clinical laboratories to quickly identify patients who need treatment and require isolation will play a critical role in preventing an outbreak.

When Patients Get Lab Test Results, Journalists May Need These Resources
SEP.24.2014 // Health Journalism
Next month, all clinical laboratories must make patients’ laboratory test results available to patients who request them.

A Revolution in Roles and Methods in Clinical Labs
SEP.26.2014 // European Hospital
Viktor Mayer-Schönberger is a visionary author of the book Big Data, which, as its subtitle suggests, defines the debate over the ‘Revolution That Will Transform How We Live, Work, and Think.

Chicago’s AACC 2014 Highlights
SEP.22.2014 // European Hospital
Never-before-seen breakthroughs in diagnostic research and technology’ were revealed during July’s American Association for Clinical Chemistry meeting in Chicago, where up to 20,000 people packed in for research updates.

A Pathologist in Your Pocket
SEP.12.2014 // European Hospital
We live in a connected world, a very different world than it was a decade ago, said Eric Topol MD. Mobile devices, wearable devices are driving a creative revolution, reducing costs of healthcare, increasing patient access to health information.

UniConnect Unveils MDx-focused Version of Lab Management Platform
AUG.8.2014 // Genome Web
UniConnect Unveils MDx-focused Version of Lab Management Platform

FDA Draft LDT Guidance Slated for Release in 60 Days; Industry Readying Recommendations, Objections
AUG.6.2014 // Genome Web
FDA Draft LDT Guidance Slated for Release in 60 Days; Industry Readying Recommendations, Objections

AB Sciex, Thermo Fisher Tout New Clinical Mass Spec Launches at AACC
AUG.1.2014 // Genome Web
AB Sciex, Thermo Fisher Tout New Clinical Mass Spec Launches at AACC